Register entryShortage reported

Prinston Pharmaceutical Inc.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
4
Live patents
0
Shortage listings
8
Countries
1
Base
United States
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Generics Bidco II LLC d/b/a Prinston LaboratoriesRegistrant: Prinston Pharmaceutical Inc.3700A Woodpark Blvd., Charlotte, North Carolina (NC) 28206, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging1038197968329537
Alert

Drug shortage listings

8
DrugPresentationStatusAvailabilityPosted / updated
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, .5 mg (NDC 43547-406-10)CurrentAvailable10 Mar 20232 Sept 2026
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, .5 mg (NDC 43547-406-11)CurrentAvailable10 Mar 20232 Sept 2026
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, .5 mg (NDC 43547-406-50)CurrentAvailable10 Mar 20232 Sept 2026
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, 1 mg (NDC 43547-407-50)CurrentAvailable10 Mar 20232 Sept 2026
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, 2 mg (NDC 43547-408-10)CurrentAvailable10 Mar 20232 Sept 2026
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, 1 mg (NDC 43547-407-11)CurrentAvailable10 Mar 20232 Sept 2026
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, 2 mg (NDC 43547-408-50)CurrentAvailable10 Mar 20232 Sept 2026
Clonazepam TabletNeurology, Pediatric, PsychiatryClonazepam, Tablet, 1 mg (NDC 43547-407-10)CurrentAvailable10 Mar 20232 Sept 2026
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: ANDA 4.

Dosage formNDCs
tablet, film coated4
RouteNDCs
oral4
Labeller name on the listingNDCs
prinston pharmaceutical inc.4
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
LevetiracetamLevetiracetamtablet, film coated, oral76494-528ANDA
LevetiracetamLevetiracetamtablet, film coated, oral76494-529ANDA
LevetiracetamLevetiracetamtablet, film coated, oral76494-530ANDA
LevetiracetamLevetiracetamtablet, film coated, oral76494-531ANDA
Neighbours

Registered in the same town

3
Compare

Comparable companies in United States

Enquiry

Common questions

Is Prinston Pharmaceutical Inc. FDA approved?
Prinston Pharmaceutical Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Prinston Pharmaceutical Inc.'s drugs manufactured?
The FDA register lists Charlotte, NC. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Prinston Pharmaceutical Inc. make?
4 products are listed under Prinston Pharmaceutical Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Are any Prinston Pharmaceutical Inc. products in shortage?
8 presentations are currently listed in the FDA drug shortage database under Prinston Pharmaceutical Inc., covering Clonazepam Tablet.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.